Patent · US Expired

Sulfonamido substituted imidazopyridines

US6525064B1 · kind B1 · utility

194Cited by
32References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 2002
Grant dateFeb 25, 2003
Priority date
Expiry dateJun 7, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Imidazopyridine compounds that contain sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.